s u m m a r y
Background & aims: HIV-infected adults have increased risk of several individual micronutrient deficiencies. However, the prevalence and risk factors of concurrent and multiple micronutrient deficiencies and whether micronutrient concentrations change after antiretroviral therapy (ART) initiation have not been well described. The objective of this study was to determine the prevalence and risk factors of individual, concurrent and multiple micronutrient deficiencies among ART-naïve HIV-infected adults from nine countries and assess change in micronutrient status 48 weeks post-ART initiation. Methods: A random sub-cohort (n ¼ 270) stratified by country was selected from the multinational PEARLS clinical trial (n ¼ 1571 ART-naïve, HIV-infected adults). We measured serum concentrations of vitamins A, D (25-hydroxyvitamin), E, carotenoids and selenium pre-ART and 48 weeks post-ART initiation, and measured vitamins B 6 , B 12 , ferritin and soluble transferrin receptor at baseline only. Prevalence of single micronutrient deficiencies, concurrent (2 coexisting) or conditional (a deficiency in one micronutrient given a deficiency in another) and multiple (!3) were determined using defined serum
Introduction
Micronutrients, including vitamins A, B (B 6, B 12 and others), D, E, iron, and selenium, have important roles in immunity, oxidative stress and general health. Furthermore, deficiencies of these micronutrients can adversely affect the health status of individuals, thus contributing to global morbidity and mortality [1, 2] . Individual deficiencies of many of these micronutrients are common in HIVinfected people [2] , especially in low and middle income countries potentially due to inadequate diet and high inflammation [2, 3] . Micronutrient deficiencies pose a special risk among immune suppressed HIV-infected adults resulting in an accelerated disease progression and greater treatment failure while on antiretroviral therapy (ART); some of these adverse outcomes have been reduced by multiple micronutrient supplementations [2] .
Most prior studies among HIV-infected individuals have focused on single micronutrients [2] but a description of prevalence of concurrent and multiple micronutrients are lacking. Assessing concurrent deficiencies could be important as coexisting deficiencies of two micronutrients may result in worse outcomes than with a single micronutrient deficiency alone as observed with anemia [4] . Deficiency prevalence of multiple (!3 deficiencies) micronutrients and to what degree this varies by factors such as country, gender, CD4 count, body mass index (BMI) and viral load is not well studied. Lastly, how micronutrient status changes post-ART initiation has also not been well described. Few studies have reported micronutrient concentrations among adults already on ART but with either no comparison group or having only used a control group comprised of other adults not on ART [2] ; longitudinal analyses of micronutrient status among individuals preand post-ART initiation is much needed.
To address these issues, we selected a geographically diverse sub-cohort comprised of ART-naïve adults with advanced HIV infection from the multinational AIDS Clinical Trials Group (ACTG) Prospective Evaluation of Antiretrovirals in Resource Limited Settings (PEARLS) trial [5] . We describe the pre-ART prevalence of single, concurrent and multiple micronutrient deficiencies using a comprehensive panel of micronutrients and explore changes after ART initiation.
Materials and methods

Study population and design
The sub-cohort used for this analysis was selected from ACTG PEARLS A5175 study (clinicaltrials.gov NCT00084136), a randomized clinical trial of ART among 1571 ART-naïve, HIV-infected adults (!18 years old) with a CD4þ T-cell count less than 300 cells/mm 3 . The methods and procedures of the PEARLS trial have been described in detail elsewhere [5] . In brief, the study was conducted from May 2005 to May 2010 and enrolled participants from nine countries: Brazil (n ¼ 231), Haiti (n ¼ 100), India (n ¼ 255), Malawi (n ¼ 221), Peru (n ¼ 134), South Africa (n ¼ 210), Thailand (n ¼ 100), United States (n ¼ 210) and Zimbabwe (n ¼ 110). Exclusion criteria included pregnancy, acute illness or other co-morbidities. One of three different ART regimens were randomly allocated with equal probability among the participants: 1) efavirenz plus twice-daily lamivudine-zidovudine; 2) once-daily atazanavir plus didanosine EC and emtricitabine; or 3) once-daily efavirenz plus emtricitabine-tenofovir-DF.
For this analysis, we selected a stratified random sample (N ¼ 270) of 30 participants from each of the nine countries. To evaluate pre-ART and post-ART micronutrient concentration and deficiency status, serum samples were obtained from the subcohort prior to ART initiation and at 48 weeks on ART. All available samples were stored at À80 C until the time of testing, and collection and storage of samples were standardized across different sites. Quantified micronutrients included retinol, a-carotene, b-carotene, b-cryptoxanthin, lutein, zeaxanthin, lycopene, vitamin B 6 , vitamin B 12 , vitamin D, a-tocopherol, transferrin receptor, ferritin, C-reactive protein (CRP), and selenium. From our random cohort of 270 ART-naïve HIV-infected adults, we were able to measure micronutrient concentrations in 252 individuals after accounting for missing samples due to low plasma volume or regulatory complications with exporting samples from India (unable to export approximately 40% of samples from India). Measured concentrations of these micronutrients were used to estimate prevalence of single and multiple micronutrient deficiencies among the sub-cohort prior to ART initiation and to assess changes in micronutrient status at 48 weeks on ART.
Ethics statement
We received approval from this study from the ethics committees and institutional review board from Johns Hopkins School of Medicine and each participating institution. We also obtained written informed consent from all participants and followed guidelines for human experimentation from the United States Department of Health and Human Services.
Laboratory analysis
Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to measure concentrations of plasma C-reactive protein (CRP) (R & D Systems), serum soluble transferrin receptor (R & D Systems), and serum ferritin (ALPCO). Total (vitamin D 2 and D 3 ) serum 25-hydroxyvitamin was measured using a radioimmunoassay (DiaSorin, Stillwater, MN) as previously described [6] . Serum vitamin B 12 concentration was measured using Abbott AxSYM (Abbott Laboratories), an automated immunochemical analyzer. Serum vitamin B 6 was measured using high-performance liquid chromatography (HPLC) with fluorescence detection [7] . Serum retinol (vitamin A), a-carotene, b-carotene, b-cryptoxanthin, lutein, zeaxanthin, lycopene and a-tocopherol (vitamin E) were measured using HPLC as previously described [8] . A PerkinseElmer AAnalyst 600 graphite furnace atomic absorption spectrometer was used to measure serum selenium concentrations [9] . Retinol, a-carotene, bcarotene, b-cryptoxanthin, lutein, zeaxanthin, lycopene, a-tocopherol, selenium and vitamin D concentrations were measured at baseline and at week 48 post-ART. Vitamin B 12 , vitamin B 6 , ferritin and soluble transferrin receptor concentrations were measured only at baseline.
Micronutrient deficiency definitions
Individual micronutrient deficiencies were defined based on cutoff values of serum concentrations used in previous studies as [17] . Concentrations of a-carotene, b-carotene, b-cryptoxanthin, lutein, zeaxanthin and lycopene were added per individual to calculate total carotenoids. In the absence of a generally accepted cutoff value, low total carotenoids was defined as the lowest quartile measured pre-ART (<0.81 mmol/ L). Concurrent deficiencies were defined as coexisting deficiencies of any two micronutrients. Conditional deficiency was defined as the percent of people with a second micronutrient deficiency among people with a given deficiency of another micronutrient. Multiple micronutrient deficiencies were defined as 3 or more deficiencies when considering deficiencies of vitamin A, B 6, B 12, D, E, selenium, iron and low total carotenoids. High inflammation is defined as elevated CRP with concentrations !5 mg/L.
Statistical analyses
Median concentration (interquartile range) and prevalence (95% confidence intervals (CI)) of deficiency were estimated for each micronutrient. Multivariable logistic regression was used to determine the risk factors for individual and multiple micronutrient deficiencies. Multivariable random effects generalized models were used to estimate the mean change in micronutrient status from 0 to 48 weeks. Baseline micronutrient concentrations, gender, age, country, BMI, treatment regimen, CD4 count, and viral load were adjusted for in the models. Prevalence, risk factors and change post-ART in vitamin D status has already been described elsewhere [18, 19] , so we will limit vitamin D analysis for concurrent, conditional and multiple micronutrient deficiency analysis. STATA version 13.0 (StataCorp) was used for all statistical analyses.
Results
Study population
The median age of our study population was 35.0 years and 50.0% of the cohort were female. 12.4% of the population had a low BMI (<18.5 kg/m 2 ) and 20.6% had high BMI (>25 kg/m 2 ). Baseline median CD4 count was 178.5 cells/mm 3 and median log viral load was 5.1 copies/mL. Only 13.9% of the cohort had no micronutrient deficiency. The prevalence of having only one micronutrient deficiency was 29.2%, and the prevalence of any two, three, four, or five or more deficiencies was 24.5%, 17.6%, 10.2% and 4.6%, respectively (data not shown).
3.2. Pre-ART prevalence and risk factors of micronutrient deficiencies 3.2.1. Individual micronutrient deficiency prevalence and risk factors Using our defined cutoffs, single micronutrient deficiency prevalence was as follows: vitamin A was 17.1%, vitamin B 12 was 9.0%, vitamin B 6 was 37.3%, ID was 11.6% and vitamin E was 0% (Fig. 1 ). And as previously described by our group, deficiency of selenium was 53.2% [20] . Risk factors associated with individual micronutrient deficiencies were assessed in multivariable models including covariates of gender, country, BMI, CD4 count and viral load. Country was the most common risk factor associated with most micronutrient deficiencies. (Table 1) .
Among participants with at least one micronutrient deficiency, conditional deficiency of vitamin B 6 , vitamin D and selenium was also common ( Table 2 ). The prevalence of concurrent seleniumvitamin D-vitamin B 6 deficiency was 12.1% (data not shown).
Multiple micronutrient deficiencies of any three or more micronutrients were common in India (prevalence of 40%), Malawi (50%), Peru (53%), South Africa (35%) and Zimbabwe (50%) but less common in Brazil (24%), Haiti (7%), Thailand (27%) and USA (21% (Fig. 2D ).
Change in micronutrient status post-ART initiation
Compared to pre-ART measurements, mean micronutrient concentrations (except for vitamin E) changed significantly by 48 weeks on ART. Table 3 shows the median concentration and prevalence of deficiency for the micronutrients at week 48 on ART. In addition, the mean change adjusted for covariates at week 48 compared to baseline is also shown. By 48 weeks on ART, mean concentrations increased for: vitamin A (mean change: 0.21 mmol/L, 95% CI: 0.14e0.28), total carotenoid (mean change: 0.18 mmol/L, CI: 0.09e0.27), vitamin E (mean change: 0.75 mmol/L, CI: À0.04to1.53) and selenium (mean change: 3.97 mg/L, CI: 2.15e5.79) ( Table 3) .
However, corresponding changes in the prevalence of individual micronutrient deficiencies were minimal, including the prevalence of vitamin E deficiency (0% at both time points), selenium deficiency (53.2%e50.0%) and low total carotenoids (25.0%e20.4%) ( Table 3 ). More substantial change was observed vitamin A deficiency prevalence, which decreased from 17.1% to 8.1%.
Discussion
This study is among the first to comprehensively assess the pre-ART prevalence and risk factors of multiple micronutrient deficiencies among adults with advanced HIV disease from diverse geographical settings while exploring longitudinal changes in micronutrient concentrations on ART among the same cohort. Overall, our analysis indicates that individual and multiple micronutrient deficiencies are common among ART-naïve HIV-infected adults, particularly involving vitamin B 6 , vitamin D and selenium, but range widely between countries. After ART initiation, our the reference group for CD4 count and viral load categories with log viral load less than 4 copies/mL were the reference group for viral load. For vitamin A, B 6 , B 12 and multiple deficiencies, the reference countries were Thailand, South Africa, Peru and Haiti, respectively. The country with the lowest non-zero prevalence of deficiency was chosen as the reference country for each micronutrient. Deficiencies are based on cutoffs used in Table 1 . analysis identified significant changes in mean concentration among all micronutrients assessed at 48 weeks on ART. However, corresponding changes in deficiency prevalence were minimal, except for decreased vitamin A deficiency, which suggests ART alone is not enough to improve micronutrient deficiency states. Previous studies have assessed individual micronutrient deficiencies among ART-naïve, HIV-infected populations. Based on historical data from HIV-uninfected people, our results are consistent with several studies and suggest that concentrations of vitamin A, vitamin B 12 , vitamin E, and selenium are lower in ARTnaïve, HIV-infected people than HIV-uninfected people [21e23], whereas concentrations of the carotenoids, vitamin B 6 and iron are similar among HIV-infected and uninfected people [21e26]. Higher prevalence of some micronutrient deficiencies among HIV-infected adults could be due to reduced intake, increased micronutrient losses through altered mucosal immunity and gut permeability, increased inflammation and interference of metabolic pathways that could potentially result from the infection [2, 3] .
While our study had similar concentrations of vitamin A compared to studies of ART-naïve HIV-infected adults in Thailand and USA [21, 22, 26] , two other studies conducted in Tanzania and France had higher concentrations but were conducted among children and pregnant women [23, 27] . Carotenoids, vitamin B 6 , vitamin B 12 and vitamin E levels were similar between our study and other studies [21e26] . Range of concentrations of selenium and ferritin varied greatly between studies and are to be expected given the well-known differences by country and race [21e26].
The wide variation in micronutrient deficiencies by country is expected given country-based differences in diet, income and other factors. Notably, income status (high versus low income status) of the country does not reliably predict deficiency patterns. For example, USA has a relatively high prevalence of vitamin B 6 deficiency (30%) while there is a lack of vitamin B 12 deficiency in Malawi. Thus, when considering worldwide supplementation such as for PEPFAR programs, it is essential to determine the deficiency status for each country and likely for specific populations (e.g. children, non-pregnant women, pregnant women, adult males).
Given the risk of negative effects of overconsumption of micronutrients in an already sufficient population [2] , different plans might be needed for different countries and populations.
There is often clustering of micronutrient deficiencies, especially in resource-limited settings where food sources are lacking in more than one micronutrient. We are not aware of any other study that has estimated the prevalence of concurrent, conditional and multiple micronutrient deficiencies in ART-naïve HIV infected people. We observed high prevalence of concurrent and multiple micronutrient deficiencies with high deficiencies of vitamin B 6 , vitamin D and selenium. Diets poor in common sources of vitamin B 6 , vitamin D and selenium, such as meat (vitamin B 6 and selenium) or nuts (selenium and vitamin B 6 ), could contribute to clustering of these deficiencies. Although comparisons with healthy populations remain scarce, a study of pregnant women in Nepal [14] reported lower prevalence of concurrent vitamin D and vitamin B 6 (7.1%) deficiencies compared to our study (19.6%). Among people with any micronutrient deficiency, conditional vitamin B 6 deficiency was likely, which is consistent with our results, but conditional vitamin D deficiency was lower (<20%) than in our study (40e55%). Our population from diverse races and countries as well as changes occurring during HIV infection or pregnancy might contribute to the different vitamin D findings between the studies. Persons with high inflammation and persons from certain countries were more likely to have multiple concurrent deficiencies and might benefit from multiple micronutrient supplementations, but this remains to be proven.
We observed increases in most micronutrients by 48 weeks on ART compared to pre-ART values. However, most of these increases were relatively small. Importantly, only vitamin A change resulted in a substantial reduction in proportion with deficiency. Thus it appears that despite effective ART, most with baseline deficiencies remain deficient after 1 year on ART. The increases (albeit small) in micronutrient concentrations could be explained by increased appetite after ART initiation resulting in greater food intake and increased weight [28] . In addition, with control of viral replication, the direct effects of the virus on micronutrient status could also be The number (n) of people with an individual micronutrient deficiency, the prevalence (%) of individual micronutrient deficiency and the conditional deficiencies are presented for each micronutrient. Conditional deficiency is defined as: given a deficiency in one micronutrient, the percent of people (prevalence) with another micronutrient deficiency. Cutoffs values for deficiency are defined in Table 1 . altered, including reduced inflammation, improved gut permeability and reduced interference with metabolic pathways. Vitamin A deficiency might have decreased from baseline due to better absorption of fat-soluble vitamins after viral control during treatment [29] . Another reason might be that retinol is as an acute phase reactant and controlling for HIV infection might have reduced the acute phase response [15] . There is a lack of studies that have prospectively followed ARTnaïve individuals to assess the change in micronutrient status post-ART. Cross-sectional studies assessing micronutrient concentrations in people already on ART show similar vitamin A deficiency and concentrations of carotenoids compared to post-ART individuals in our study [15, 29] . Concentrations and prevalence of vitamin E deficiency post-ART were also similar between our study and others studies [29, 30] . As described with pre-ART levels, selenium concentrations varied widely between countries as is expected due to variations between soil selenium content and food sources by country [20] .
Strengths of this study include the estimates of multiple micronutrient deficiencies, as well as the longitudinal follow-up of the same cohort of individuals pre-and post-ART. One weakness of our study is the use of serum concentrations to define micronutrient deficiency although serum concentrations might not always represent true deficiency. However, serum-based cutoffs are commonly used and here we report a summary of serum-based cutoffs of deficiency with adjustment for confounders such as inflammation in risk factor analysis. The lack of HIV-uninfected control group due to its nesting within a randomized controlled trial of HIV-infected people is also a limitation. However historical data from other studies were available for comparison purposes. Another limitation was that data on nutrient supplementation was missing in the parent trial. Although supplementation use was likely low in most sites, this information would have been useful. Finally, our sample size for each country though low was based on a random stratified sample so prevalence estimation could be performed.
In summary, multiple micronutrient deficiencies were common prior to ART initiation and after ART initiation. This suggests that ART alone may not correct many micronutrient deficiencies. For deficiencies associated with adverse treatment outcomes, supplementation should be considered but only in settings with deficiencies.
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